| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $360.7M | -11.0% |
| Cost of Revenue | $159.1M | -21.3% |
| Gross Profit | $201.6M | -0.8% |
| R&D Expense | $1.3M | +116.7% |
| SG&A Expense | $122.4M | -2.1% |
| Operating Income | $80.8M | -2.1% |
| Pre-tax Income | $65.0M | +5.3% |
| Income Tax | $16.9M | -29.2% |
| Net Income | $39.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.9M | -58.5% |
| Accounts Receivable | $9.6M | -3.7% |
| Inventory | $96.3M | -2.7% |
| Current Assets | $198.2M | -25.9% |
| Total Assets | $493.4M | -13.3% |
| Current Liabilities | $44.8M | -55.3% |
| Long-term Debt | $248.6M | -19.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $67.1M | +0.3% |
| Capital Expenditures | $4.6M | -19.0% |
| Investing Cash Flow | -$10.5M | -77.9% |
| Financing Cash Flow | -$128.3M | -159.1% |
| Free Cash Flow | $62.4M | +2.1% |
| +3.5% |
| EPS (Basic) | $2.24 | +2.3% |
| EPS (Diluted) | $2.14 | +6.5% |
| Total Liabilities |
| $303.0M |
| -27.4% |
| Stockholders' Equity | $190.4M | +26.1% |